Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol

ClinicalTrials.gov ID: NCT00143663

Public ClinicalTrials.gov record NCT00143663. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 12:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 100 mg Versus Placebo in Subjects With Primary Hypercholesterolemia

Study identification

NCT ID
NCT00143663
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
361 participants

Conditions and interventions

Conditions

Interventions

  • Lapaquistat Acetate Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2005
Primary completion
Mar 31, 2006
Completion
Mar 31, 2006
Last update posted
May 23, 2012

2005 – 2006

United States locations

U.S. sites
47
U.S. states
23
U.S. cities
47
Facility City State ZIP Site status
Not listed Northport Alabama
Not listed Mesa Arizona
Not listed Chula Vista California
Not listed Encinitas California
Not listed Long Beach California
Not listed Pismo Beach California
Not listed Sacramento California
Not listed San Diego California
Not listed Golden Colorado
Not listed Aventura Florida
Not listed Clearwater Florida
Not listed Daytona Beach Florida
Not listed Hollywood Florida
Not listed Jacksonville Florida
Not listed Jupiter Florida
Not listed New Port Richy Florida
Not listed Pembroke Pines Florida
Not listed Elk Grove Village Illinois
Not listed Peoria Illinois
Not listed Evansville Indiana
Not listed Indianapolis Indiana
Not listed Arkansas City Kansas
Not listed Wichita Kansas
Not listed Louisville Kentucky
Not listed Livonia Michigan
Not listed Las Vegas Nevada
Not listed Margate City New Jersey
Not listed New Hyde Park New York
Not listed Charlotte North Carolina
Not listed Raleigh North Carolina
Not listed Statesville North Carolina
Not listed Wilmington North Carolina
Not listed Winston-Salem North Carolina
Not listed Medford Oregon
Not listed Downingtown Pennsylvania
Not listed Sellersville Pennsylvania
Not listed Tipton Pennsylvania
Not listed Warwick Rhode Island
Not listed Charleston South Carolina
Not listed Mt. Pleasant South Carolina
Not listed Bristol Tennessee
Not listed Dallas Texas
Not listed San Antonio Texas
Not listed Ogden Utah
Not listed Norfolk Virginia
Not listed Richmond Virginia
Not listed Madison Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00143663, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 23, 2012 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00143663 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →